Selected research
Industry Growth & Trends
Global Immuno-Oncology Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Immuno-Oncology Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Immuno-Oncology Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Immuno-Oncology Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Immuno-Oncology Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Immuno-Oncology Service market include Crown Bioscience, Bio-Techne, Abcam, WuXi AppTec, Shanghai ChemPartner, George Clinical, Laboratory Corporation of America® Holdings, Medpace and Genscript, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Immuno-Oncology Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Immuno-Oncology Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Immuno-Oncology Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Immuno-Oncology Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Immuno-Oncology Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Immuno-Oncology Service Market by Company
Crown Bioscience
Bio-Techne
Abcam
WuXi AppTec
Shanghai ChemPartner
George Clinical
Laboratory Corporation of America® Holdings
Medpace
Genscript
Shanghai Novamab Biopharmaceuticals
LIDE
TransCure bioServices
Immuno-Oncology Service Segment by Type
Basic Research
Clinical Research
Immuno-Oncology Service Segment by Application
Pharmaceutical Companies
Medical Device Companies
Other
Immuno-Oncology Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immuno-Oncology Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immuno-Oncology Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immuno-Oncology Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Immuno-Oncology Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Basic Research
- Clinical Research
Applications
- Pharmaceutical Companies
- Medical Device Companies
- Other
Companies covered
- Crown Bioscience
- Bio-Techne
- Abcam
- WuXi AppTec
- Shanghai ChemPartner
- George Clinical
- Laboratory Corporation of America® Holdings
- Medpace
- Genscript
- Shanghai Novamab Biopharmaceuticals
- LIDE
- TransCure bioServices
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Immuno-Oncology Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Immuno-Oncology Service Market Size by Region (2021-2032)
- 1.4.1 Global Immuno-Oncology Service Market Size by Region (2021-2026)
- 1.4.2 Global Immuno-Oncology Service Market Size by Region (2027-2032)
- 1.5 Key Regions Immuno-Oncology Service Market Size (2021-2032)
- 1.5.1 North America Immuno-Oncology Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Immuno-Oncology Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Immuno-Oncology Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Immuno-Oncology Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Immuno-Oncology Service Market Size Growth Rate (2021-2032)
2 Immuno-Oncology Service Market by Type
- 2.1 Type Introduction
- 2.1.1 Basic Research
- 2.1.2 Clinical Research
- 2.2 Global Immuno-Oncology Service Market Size by Type
- 2.2.1 Global Immuno-Oncology Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Immuno-Oncology Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Immuno-Oncology Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Immuno-Oncology Service Market Size by Regions
- 2.3.1 North America Immuno-Oncology Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Immuno-Oncology Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Immuno-Oncology Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Immuno-Oncology Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Immuno-Oncology Service Market Size Breakdown by Type (2021-2026)
3 Immuno-Oncology Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Pharmaceutical Companies
- 3.1.2 Medical Device Companies
- 3.1.3 Other
- 3.2 Global Immuno-Oncology Service Market Size by Application
- 3.2.1 Global Immuno-Oncology Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Immuno-Oncology Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Immuno-Oncology Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Immuno-Oncology Service Market Size by Regions
- 3.3.1 North America Immuno-Oncology Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Immuno-Oncology Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Immuno-Oncology Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Immuno-Oncology Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Immuno-Oncology Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Immuno-Oncology Service Industry Trends
- 4.2 Immuno-Oncology Service Industry Drivers
- 4.3 Immuno-Oncology Service Industry Opportunities and Challenges
- 4.4 Immuno-Oncology Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Immuno-Oncology Service Revenue (2021-2026)
- 5.2 Global Immuno-Oncology Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Immuno-Oncology Service Key Company Headquarters & Area Served
- 5.4 Global Immuno-Oncology Service Company, Product Type & Application
- 5.5 Global Immuno-Oncology Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Immuno-Oncology Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Immuno-Oncology Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Immuno-Oncology Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Crown Bioscience
- 6.1.1 Crown Bioscience Company Information
- 6.1.2 Crown Bioscience Business Overview
- 6.1.3 Crown Bioscience Immuno-Oncology Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Crown Bioscience Immuno-Oncology Service Product Portfolio
- 6.1.5 Crown Bioscience Recent Developments
- 6.2 Bio-Techne
- 6.2.1 Bio-Techne Company Information
- 6.2.2 Bio-Techne Business Overview
- 6.2.3 Bio-Techne Immuno-Oncology Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Bio-Techne Immuno-Oncology Service Product Portfolio
- 6.2.5 Bio-Techne Recent Developments
- 6.3 Abcam
- 6.3.1 Abcam Company Information
- 6.3.2 Abcam Business Overview
- 6.3.3 Abcam Immuno-Oncology Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Abcam Immuno-Oncology Service Product Portfolio
- 6.3.5 Abcam Recent Developments
- 6.4 WuXi AppTec
- 6.4.1 WuXi AppTec Company Information
- 6.4.2 WuXi AppTec Business Overview
- 6.4.3 WuXi AppTec Immuno-Oncology Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 WuXi AppTec Immuno-Oncology Service Product Portfolio
- 6.4.5 WuXi AppTec Recent Developments
- 6.5 Shanghai ChemPartner
- 6.5.1 Shanghai ChemPartner Company Information
- 6.5.2 Shanghai ChemPartner Business Overview
- 6.5.3 Shanghai ChemPartner Immuno-Oncology Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Shanghai ChemPartner Immuno-Oncology Service Product Portfolio
- 6.5.5 Shanghai ChemPartner Recent Developments
- 6.6 George Clinical
- 6.6.1 George Clinical Company Information
- 6.6.2 George Clinical Business Overview
- 6.6.3 George Clinical Immuno-Oncology Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 George Clinical Immuno-Oncology Service Product Portfolio
- 6.6.5 George Clinical Recent Developments
- 6.7 Laboratory Corporation of America® Holdings
- 6.7.1 Laboratory Corporation of America® Holdings Company Information
- 6.7.2 Laboratory Corporation of America® Holdings Business Overview
- 6.7.3 Laboratory Corporation of America® Holdings Immuno-Oncology Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Laboratory Corporation of America® Holdings Immuno-Oncology Service Product Portfolio
- 6.7.5 Laboratory Corporation of America® Holdings Recent Developments
- 6.8 Medpace
- 6.8.1 Medpace Company Information
- 6.8.2 Medpace Business Overview
- 6.8.3 Medpace Immuno-Oncology Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Medpace Immuno-Oncology Service Product Portfolio
- 6.8.5 Medpace Recent Developments
- 6.9 Genscript
- 6.9.1 Genscript Company Information
- 6.9.2 Genscript Business Overview
- 6.9.3 Genscript Immuno-Oncology Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Genscript Immuno-Oncology Service Product Portfolio
- 6.9.5 Genscript Recent Developments
- 6.10 Shanghai Novamab Biopharmaceuticals
- 6.10.1 Shanghai Novamab Biopharmaceuticals Company Information
- 6.10.2 Shanghai Novamab Biopharmaceuticals Business Overview
- 6.10.3 Shanghai Novamab Biopharmaceuticals Immuno-Oncology Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Shanghai Novamab Biopharmaceuticals Immuno-Oncology Service Product Portfolio
- 6.10.5 Shanghai Novamab Biopharmaceuticals Recent Developments
- 6.11 LIDE
- 6.11.1 LIDE Company Information
- 6.11.2 LIDE Business Overview
- 6.11.3 LIDE Immuno-Oncology Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 LIDE Immuno-Oncology Service Product Portfolio
- 6.11.5 LIDE Recent Developments
- 6.12 TransCure bioServices
- 6.12.1 TransCure bioServices Company Information
- 6.12.2 TransCure bioServices Business Overview
- 6.12.3 TransCure bioServices Immuno-Oncology Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 TransCure bioServices Immuno-Oncology Service Product Portfolio
- 6.12.5 TransCure bioServices Recent Developments
7 North America
- 7.1 North America Immuno-Oncology Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Immuno-Oncology Service Market Size by Country (2021-2026)
- 7.3 North America Immuno-Oncology Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Immuno-Oncology Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Immuno-Oncology Service Market Size by Country (2021-2026)
- 8.3 Europe Immuno-Oncology Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Immuno-Oncology Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Immuno-Oncology Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Immuno-Oncology Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Immuno-Oncology Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Immuno-Oncology Service Market Size by Country (2021-2026)
- 10.3 South America Immuno-Oncology Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Immuno-Oncology Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Immuno-Oncology Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Immuno-Oncology Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst